Combinatorial Antigen Targeting: Ideal T-Cell Sensing and Anti-Tumor Response

被引:8
|
作者
Themelil, Maria [1 ]
Sadelain, Michel [2 ,3 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Hematol, NL-1081 HV Amsterdam, Netherlands
[2] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA
关键词
D O I
10.1016/j.molmed.2016.02.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T cells expressing chimeric antigen receptors (CARs) are a formidable platform for the study and application of synthetic biology approaches to study customized and flexible control of cellular functions. Recent reports in the journal Cell provide a new twist on combinatorial antigen targeting, profiting from the singular cleavage and signaling of the Notch receptor to conditionally express CARs.
引用
收藏
页码:271 / 273
页数:3
相关论文
共 50 条
  • [1] Improving anti-tumor response by increasing mitochondrial respiration of T-cell
    Wu, Meng-Han
    Giddlings, Emily
    Danis, Catherine
    McCalab, Megan
    Kohler, Mark Eric
    Rincon, Mercedes
    CANCER RESEARCH, 2022, 82 (12)
  • [2] BIOLOGICAL RESPONSE MODIFIER AS ANTIGEN - OK432-SPECIFIC T-CELL CLONE AS AN ANTI-TUMOR EFFECTOR CELL
    OZAKI, S
    SUGINOSHITA, T
    CELLULAR IMMUNOLOGY, 1989, 120 (02) : 477 - 481
  • [3] Targeting the Stroma to Enhance T-Cell Infiltration and Anti-tumor Response to Anti-PD1 Antibody in Pancreatic Ductal Adenocarcinoma
    Osipov, A.
    Zheng, L.
    PANCREAS, 2020, 49 (10) : 1422 - 1423
  • [4] Tetracyclines Enhance Anti-tumor T-Cell Responses Induced by a Bispecific T-Cell Engager
    Noguchi, Yuki
    Yamamoto, Yoko
    Iwahori, Kota
    Matsumoto, Mitsunobu
    Hirata, Michinari
    Okuyama, Hiroomi
    Shintani, Yasushi
    Kumanogoh, Atsushi
    Wada, Hisashi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (04) : 429 - 437
  • [5] Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity
    Ping, Yu
    Shen, Chunyi
    Huang, Bo
    Zhang, Yi
    CELLS, 2022, 11 (19)
  • [6] Combinatorial targeting polymeric micelles for anti-tumor drug delivery
    Yang, Saina
    Zhu, Feiyan
    Wang, Qian
    Liang, Fuxin
    Qu, Xiaozhong
    Gan, Zhihua
    Yang, Zhenzhong
    JOURNAL OF MATERIALS CHEMISTRY B, 2015, 3 (19) : 4043 - 4051
  • [7] Generation of novel anti-tumor chimeric antigen receptors incorporating downstream T-cell signaling proteins
    Angeles, Benjamin C.
    Moreno, Taylor
    Balagopalan, Lakshmi
    Yi, Jason
    Qin, Haiying
    Alvinez, Neriah
    Yamane, Hide
    Lee, Mariah
    Pallikkuth, Sandeep
    Tran, Andy
    McIntire, Katherine
    Taylor, Naomi
    Samelson, Lawrence E.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [8] Targeting the ICOS pathway in combination with chemotherapy to enhance T-cell mediated anti-tumor immune responses
    Mahmoud, Tamer
    Riggs, Jeffrey
    Ramaswamy, Madhu
    Hostetler, Leigh
    Naiman, Brian
    Ramos, Ilyssa
    Turman, Sean
    Pilataxi, Fernanda
    Morehouse, Christopher
    Alfaro, Alex
    Peterson, Norman
    Fleming, Ryan
    Dimasi, Nazzareno
    Kuszpit, Kyle
    Herbst, Ronald
    Carlesso, Gianluca
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity
    Canel, Marta
    Taggart, David
    Sims, Andrew H.
    Lonergan, David W.
    Waizenegger, Irene C.
    Serrels, Alan
    ELIFE, 2020, 9
  • [10] Chimeric antigen receptor T cells targeting primary CNS lymphoma: Visualizing the anti-tumor response in vivo
    Mulazzani, Matthias
    Frassle, Simon
    Buchholz, Veit
    Straube, Andreas
    Busch, Dirk
    von Baumgarten, Louisa
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)